Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF regimen) with the standard combination of 5-FU, doxorubicin and methotrexate (FAMTX) in previously untreated patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, J S, Norman, A, Cunningham, D, Scarffe, J H, Webb, A, Harper, P, Joffe, J K, Mackean, M, Mansi, J, Leahy, M, Hill, A, Oates, J, Rao, S, Nicolson, M, Hickish, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363002/
https://www.ncbi.nlm.nih.gov/pubmed/10390007
http://dx.doi.org/10.1038/sj.bjc.6690350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363002/
https://www.ncbi.nlm.nih.gov/pubmed/10390007
http://dx.doi.org/10.1038/sj.bjc.6690350

Ejemplares similares